Inovio Pharmaceuticals, Inc. financial reports, Inovio Pharmaceuticals, Inc. annual revenue in 2024. When does Inovio Pharmaceuticals, Inc. report revenue?
Inovio Pharmaceuticals, Inc. total revenue, net income and dynamics of changes in US dollar today
Inovio Pharmaceuticals, Inc. revenue for the past few reporting periods. Net revenue Inovio Pharmaceuticals, Inc. is now 371 120 $. Information about net revenue is taken from open sources. These are the main financial indicators of Inovio Pharmaceuticals, Inc.. Graph of finance company Inovio Pharmaceuticals, Inc.. The financial report schedule from 30/06/2017 to 31/03/2021 is available online. All information on Inovio Pharmaceuticals, Inc. total revenue on this chart is created in the form of yellow bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
371 120 $
-86.886 % ↓
-54 402 131 $
-
31/12/2020
5 580 581 $
+122.99 % ↑
-24 338 380 $
-
30/09/2020
236 178 $
-72.755 % ↓
19 171 336 $
-
30/06/2020
267 187 $
+96.93 % ↑
-128 703 059 $
-
30/09/2019
866 863 $
-
-23 090 693 $
-
30/06/2019
135 673 $
-
-29 387 226 $
-
31/03/2019
2 829 905 $
-
-29 219 262 $
-
31/12/2018
2 502 624 $
-
-32 962 205 $
-
30/09/2018
2 000 868 $
-
-25 015 672 $
-
30/06/2018
24 448 761 $
-
-6 639 125 $
-
31/03/2018
1 529 644 $
-
-32 350 828 $
-
31/12/2017
8 787 234 $
-
-21 506 179 $
-
30/09/2017
2 644 543 $
-
-34 134 570 $
-
30/06/2017
20 412 124 $
-
-9 479 116 $
-
Show:
to
Inovio Pharmaceuticals, Inc. financial report charts
Dates of Inovio Pharmaceuticals, Inc. finance reports: 30/06/2017, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Inovio Pharmaceuticals, Inc. is 31/03/2021. Gross profit Inovio Pharmaceuticals, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Inovio Pharmaceuticals, Inc. is -38 673 298 $
Inovio Pharmaceuticals, Inc. quarterly report dates
Cost of revenue Inovio Pharmaceuticals, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Inovio Pharmaceuticals, Inc. is 39 044 418 $ Total revenue Inovio Pharmaceuticals, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Inovio Pharmaceuticals, Inc. is 371 120 $ Operating income Inovio Pharmaceuticals, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Inovio Pharmaceuticals, Inc. is -52 554 492 $
Net income Inovio Pharmaceuticals, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Inovio Pharmaceuticals, Inc. is -54 402 131 $ Current assets Inovio Pharmaceuticals, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Inovio Pharmaceuticals, Inc. is 588 434 836 $ Total assets Inovio Pharmaceuticals, Inc. refers to the total amount of assets owned by a person or entity. Total assets Inovio Pharmaceuticals, Inc. is 654 863 350 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-38 673 298 $
-20 721 980 $
-26 218 934 $
-22 109 388 $
-16 370 346 $
-22 350 593 $
-21 559 983 $
-23 863 023 $
-19 850 990 $
1 986 141 $
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
39 044 418 $
26 302 561 $
26 455 112 $
22 376 575 $
17 237 209 $
22 486 266 $
24 389 888 $
26 365 647 $
21 851 858 $
22 462 620 $
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
371 120 $
5 580 581 $
236 178 $
267 187 $
866 863 $
135 673 $
2 829 905 $
2 502 624 $
2 000 868 $
24 448 761 $
1 529 644 $
8 787 234 $
2 644 543 $
20 412 124 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
866 863 $
135 673 $
2 829 905 $
2 502 624 $
2 000 868 $
24 448 761 $
1 529 644 $
8 787 234 $
2 644 543 $
20 412 124 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-52 554 492 $
-29 339 438 $
-36 329 440 $
-33 180 898 $
-21 774 787 $
-28 200 694 $
-28 535 012 $
-29 499 164 $
-26 642 683 $
-5 203 169 $
-32 746 122 $
-23 887 789 $
-29 185 471 $
-9 635 733 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-54 402 131 $
-24 338 380 $
19 171 336 $
-128 703 059 $
-23 090 693 $
-29 387 226 $
-29 219 262 $
-32 962 205 $
-25 015 672 $
-6 639 125 $
-32 350 828 $
-21 506 179 $
-34 134 570 $
-9 479 116 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
22 486 266 $
24 389 888 $
24 389 888 $
24 389 888 $
24 389 888 $
24 577 751 $
24 641 124 $
25 510 239 $
23 878 751 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
52 925 612 $
34 920 019 $
36 565 618 $
33 448 085 $
22 641 650 $
28 336 367 $
31 364 917 $
32 001 788 $
28 643 551 $
29 651 930 $
34 275 766 $
32 675 023 $
31 830 014 $
30 047 857 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
588 434 836 $
471 170 690 $
377 064 673 $
382 062 453 $
98 812 541 $
110 509 032 $
134 902 998 $
87 814 824 $
93 602 784 $
101 840 800 $
123 836 168 $
138 362 160 $
154 587 804 $
106 877 598 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
654 863 350 $
539 772 472 $
437 814 047 $
443 185 402 $
151 533 430 $
165 073 296 $
191 165 508 $
131 113 265 $
140 696 347 $
148 923 066 $
173 664 840 $
187 239 270 $
203 680 028 $
158 853 213 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
83 634 176 $
250 728 118 $
178 700 434 $
215 432 713 $
15 853 236 $
19 735 943 $
20 779 152 $
23 693 633 $
19 397 822 $
15 085 643 $
37 508 863 $
23 786 579 $
23 278 392 $
23 860 637 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
19 546 853 $
24 079 328 $
27 415 047 $
35 299 759 $
27 998 015 $
28 406 271 $
-
-
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
112 768 752 $
127 425 423 $
141 889 993 $
91 999 256 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
115 414 698 $
108 595 223 $
110 199 257 $
44 080 858 $
36 987 173 $
37 431 246 $
-
-
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
76.16 %
65.79 %
57.65 %
33.62 %
26.29 %
25.13 %
-
-
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
581 606 149 $
461 140 758 $
323 903 846 $
186 264 200 $
33 693 570 $
53 616 904 $
77 909 480 $
86 936 138 $
103 612 905 $
111 395 551 $
112 998 294 $
142 392 540 $
162 022 911 $
123 433 348 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-27 733 458 $
-23 924 984 $
-32 454 347 $
-17 281 018 $
-24 670 864 $
-19 023 074 $
-12 575 200 $
-13 948 407 $
-17 313 533 $
-16 719 541 $
Last revenue report of Inovio Pharmaceuticals, Inc. was 31/03/2021. According to last financial report total revenue in Inovio Pharmaceuticals, Inc. was 371 120 US dollar and changed by -86.886% since last year. Net income in Inovio Pharmaceuticals, Inc. was -54 402 131 $ in last quartal, net income changes to 0%.
Current cash Inovio Pharmaceuticals, Inc. - the sum of all of the cash a company has on the date of report. Current cash Inovio Pharmaceuticals, Inc. is 83 634 176 $
Inovio Pharmaceuticals, Inc. stocks data
INO stock price
Inovio Pharmaceuticals, Inc. stock price today, INO stock quote.
